Clinical Trials Directory

Trials / Unknown

UnknownNCT06212882

Optimization of DE-CTPA Images and Diagnostic Pathway: Using Low Concentration Iodine Contrast Material

Dual-Energy CT Angiography in Suspected Pulmonary Embolism: Influence of Concentration of Contrast Materials on Image Quality and Diagnostic Performance

Status
Unknown
Phase
Study type
Observational
Enrollment
2,100 (estimated)
Sponsor
Wuxi People's Hospital · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The investigators aimed to compare the image quality and diagnostic performance of DECTPA using lower concentration iodine contrast materials and using normal concentration iodine contrast materials in the evaluation of suspected pulmonary embolism.

Detailed description

All patients met the inclusion and exclusion criteria will be given written informed consensus. The enrolled patients will randomly receive one of the three injection protocols: A: 30mL Iomeprol (Iomeron 300, Bracco Imaging, Milano, Italia) injected at a flow rate of 4mL/s; B: 50mL Iomeprol (Iomeron 300, Bracco Imaging, Milano, Italia) injected at a flow rate of 4mL/s; C: 50mL Ioversol (Ioversol 350, Hengrui, Jiansun, China) injected at a flow rate of 4mL/s. A and B groups are both lower concentration iodine contrast material groups, with different total iodine loads.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTLower concentration and lower volume contrast agent groupCT images using lower concentration and lower volume contrast material

Timeline

Start date
2023-09-01
Primary completion
2024-11-01
Completion
2025-06-01
First posted
2024-01-19
Last updated
2024-01-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06212882. Inclusion in this directory is not an endorsement.